VCIM

Velan Capital Investment Management Portfolio holdings

AUM $106M
1-Year Est. Return 171.31%
This Quarter Est. Return
1 Year Est. Return
+171.31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$99.9M
AUM Growth
+$2.74M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
57
New
Increased
Reduced
Closed

Top Buys

1
+$4.87M
2
+$4.86M
3
+$3.68M
4
RZLT icon
Rezolute
RZLT
+$1.56M
5
STRO icon
Sutro Biopharma
STRO
+$1.45M

Top Sells

1
+$8.32M
2
+$8.19M
3
+$1.5M
4
TIL icon
Instil Bio
TIL
+$1.2M
5
IMNM icon
Immunome
IMNM
+$1.03M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRBP icon
26
Corbus Pharmaceuticals
CRBP
$180M
$407K 0.4%
59,000
KPRX icon
27
Kiora Pharmaceuticals
KPRX
$6.95M
$352K 0.35%
122,223
PTGX icon
28
Protagonist Therapeutics
PTGX
$5.29B
$204K 0.2%
+3,700
CTMX icon
29
CytomX Therapeutics
CTMX
$646M
$170K 0.17%
75,000
NRIX icon
30
Nurix Therapeutics
NRIX
$1.66B
$114K 0.11%
+10,000
GERN icon
31
Geron
GERN
$785M
$98.7K 0.1%
70,000
-585,000
WVE icon
32
Wave Life Sciences
WVE
$1.17B
$97.5K 0.1%
15,000
+2,000
LRMR icon
33
Larimar Therapeutics
LRMR
$267M
$95.4K 0.09%
33,000
+5,000
GOSS icon
34
Gossamer Bio
GOSS
$692M
$92.3K 0.09%
75,000
PRQR icon
35
ProQR Therapeutics
PRQR
$205M
$91.8K 0.09%
45,000
VTYX icon
36
Ventyx Biosciences
VTYX
$567M
$85.6K 0.08%
40,000
ERAS icon
37
Erasca
ERAS
$820M
$82.5K 0.08%
65,000
+15,000
ALEC icon
38
Alector
ALEC
$124M
$77K 0.08%
55,000
TERN icon
39
Terns Pharmaceuticals
TERN
$2.32B
$74.6K 0.07%
20,000
+3,000
DSGN icon
40
Design Therapeutics
DSGN
$509M
$67.4K 0.07%
20,000
+6,000
CNTX icon
41
Context Therapeutics
CNTX
$97.4M
$65.5K 0.06%
100,000
+10,000
OVID icon
42
Ovid Therapeutics
OVID
$111M
$52.8K 0.05%
160,000
+63,000
IMMX icon
43
Immix Biopharma
IMMX
$133M
$51.8K 0.05%
+25,000
VYNE icon
44
VYNE Therapeutics
VYNE
$11.9M
$49.5K 0.05%
+30,000
ACRS icon
45
Aclaris Therapeutics
ACRS
$293M
$46.4K 0.05%
32,700
-2,300
FDMT icon
46
4D Molecular Therapeutics
FDMT
$579M
$44.5K 0.04%
12,000
PYXS icon
47
Pyxis Oncology
PYXS
$243M
$44K 0.04%
+40,000
PMVP icon
48
PMV Pharmaceuticals
PMVP
$65.5M
$37.1K 0.04%
35,000
NXTC icon
49
NextCure
NXTC
$42.5M
$20.7K 0.02%
3,750
+1,667
IMNM icon
50
Immunome
IMNM
$1.57B
– –
-153,500
1
2
3